UBT251 vs Oxyntomodulin
Head-to-head comparison of UBT251 (UBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonist) and Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | UBT251 | Oxyntomodulin |
|---|---|---|
| Category | Weight Management | Weight Management |
| Full Name | UBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonist | Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide |
| Molecular Weight | N/A | ~4,200 Da |
| Half-Life | Approximately 1 week | 12-15 minutes |
| Amino Acids | N/A | 37 |
| Typical Dose | Investigational; no established human dose | Research doses vary; commonly 100-300 mcg in small human studies |
| Route | Subcutaneous | Subcutaneous/IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 8 | 80 |
| Research Status | Pre-clinical | Clinical |
UBT251 Benefits
- ✓weight reduction
- ✓improved satiety
- ✓enhanced energy expenditure
- ✓better insulin sensitivity
Oxyntomodulin Benefits
- ✓reduces appetite
- ✓increases satiety
- ✓supports weight loss
- ✓improves postprandial metabolic signaling
UBT251 Dosing
once-weekly subcutaneous injection|dose escalation in studies|maintenance after tolerability assessment
Oxyntomodulin Dosing
Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring
UBT251 Side Effects
- ⚠nausea
- ⚠diarrhea
- ⚠fatigue
Oxyntomodulin Side Effects
- ⚠nausea
- ⚠GI discomfort
- ⚠decreased appetite beyond target
Research Overview
UBT251
Published work supports strong anti-obesity activity in preclinical models, with translation into human studies still emerging. The compound remains investigational and is best characterized as an early multi-agonist program.
Oxyntomodulin
Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.